Ryan Neal Hanney1, Colette Ridehalgh2, Allan Dawson3, Daniel Lewis4, Deirdre Kenny2. 1. University of Brighton, Faculty of Health, School of Health Professions, UK; Maidstone and Tunbridge Wells NHS Trust, UK. 2. University of Brighton, Faculty of Health, School of Health Professions, UK. 3. University of Brighton, Faculty of Health, School of Health Professions, UK; Beckenham Physiotherapy, Sports and Acupuncture Clinic, UK. 4. University of Brighton, Faculty of Health, School of Health Professions, UK; Frimley Park Hospital NHS Foundation Trust, UK.
Abstract
STUDY DESIGN: Randomized, single blind, same subject crossover trial. OBJECTIVES: To compare the effects of two neurodynamic treatment doses on range of hip flexion (ROM HF) and electromyographic (EMG) activity of semitendinosus, at first onset of pain (P1). METHODS: A total of 26 healthy participants without low back or leg pain received each treatment in a random order with at least 48 hours between sessions. Baseline ROM HF and EMG magnitude of semitendinosus at P1 were collected. Subjects then received either 361 or 362 minutes of oscillating end of range (grade IVz) straight leg raise (SLR) neurodynamic treatment and were re-assessed for baseline measures. RESULTS: There was no significant difference between groups in EMG magnitude (P50.190) and ROM HF (P50.739) at P1. There was also no significant difference within groups in EMG magnitude at P1 (P50.182); however, there was a significant improvement in ROM HF at P1 in both groups compared to baseline readings (P50.000), with increases of 6.7u and 5.1u for the 361- and 362-minute groups, respectively. CONCLUSION: Findings indicate that 362 minutes of oscillating grade IVz SLR neurodynamic treatment has no additional benefit over 361 minute, on ROM HF or EMG magnitude of semitendinosus at P1. Using an oscillating SLR treatment may, however, help to increase pain-free ROM HF, although further studies are necessary to confirm this.
RCT Entities:
STUDY DESIGN: Randomized, single blind, same subject crossover trial. OBJECTIVES: To compare the effects of two neurodynamic treatment doses on range of hip flexion (ROM HF) and electromyographic (EMG) activity of semitendinosus, at first onset of pain (P1). METHODS: A total of 26 healthy participants without low back or leg pain received each treatment in a random order with at least 48 hours between sessions. Baseline ROM HF and EMG magnitude of semitendinosus at P1 were collected. Subjects then received either 361 or 362 minutes of oscillating end of range (grade IVz) straight leg raise (SLR) neurodynamic treatment and were re-assessed for baseline measures. RESULTS: There was no significant difference between groups in EMG magnitude (P50.190) and ROM HF (P50.739) at P1. There was also no significant difference within groups in EMG magnitude at P1 (P50.182); however, there was a significant improvement in ROM HF at P1 in both groups compared to baseline readings (P50.000), with increases of 6.7u and 5.1u for the 361- and 362-minute groups, respectively. CONCLUSION: Findings indicate that 362 minutes of oscillating grade IVz SLR neurodynamic treatment has no additional benefit over 361 minute, on ROM HF or EMG magnitude of semitendinosus at P1. Using an oscillating SLR treatment may, however, help to increase pain-free ROM HF, although further studies are necessary to confirm this.